Natera (NTRA) Non-Current Deffered Revenue (2016 - 2026)
Natera's (NTRA) quarterly Non-Current Deffered Revenue came in at $17.0 million in Q1 2026, down 29.05% YoY from $24.0 million in Q1 2025, and little changed on a QoQ basis from $17.1 million in Q4 2025.
Natera (NTRA) Non-Current Deffered Revenue (2016 - 2026) Analysis & Trends
Natera (NTRA) has 11 years of Non-Current Deffered Revenue data on file, last reported at $17.0 million in Q1 2026.
- Quarterly Non-Current Deffered Revenue fell 29.05% year-over-year to $17.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.0 million (down 29.05% YoY) and the FY2025 annual result came in at $17.1 million, up 1.33% from the prior year.
- Non-Current Deffered Revenue steadied at $17.0 million in Q1 2026, from $17.1 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $25.5 million in Q3 2024 to a low of $16.8 million in Q4 2024.
- A 5-year average of $20.8 million and a median of $20.7 million in 2022 frame the typical range for Non-Current Deffered Revenue.
- Annual changes were most pronounced in 2024 — Non-Current Deffered Revenue rose 21.26% — and 2026, when it dropped 29.05%.
- Tracing NTRA's Non-Current Deffered Revenue over 5 years: stood at $20.0 million in 2022, then dropped by 4.36% to $19.1 million in 2023, then fell by 11.97% to $16.8 million in 2024, then advanced by 1.33% to $17.1 million in 2025, then retreated by 0.37% to $17.0 million in 2026.
- The last three Non-Current Deffered Revenue figures came in at $17.0 million (Q1 2026), $17.1 million (Q4 2025), and $22.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | - |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 16.07 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | - |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 32.59 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | - |
| 10 | Quest Diagnostics | 27.10 Bn | 26.47 Bn | 1.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.07 Mn |
| Mar 31, 2026 | 17.00 Mn |
| Dec 31, 2025 | 17.06 Mn |
| Dec 31, 2024 | 16.84 Mn |
| Dec 31, 2023 | 19.13 Mn |
| Sep 30, 2023 | 21.03 Mn |
| Jun 30, 2023 | 21.50 Mn |
| Mar 31, 2023 | 21.51 Mn |
| Dec 31, 2022 | 20.00 Mn |
| Sep 30, 2022 | 20.41 Mn |
| Jun 30, 2022 | 20.72 Mn |
| Mar 31, 2022 | 20.54 Mn |
| Dec 31, 2021 | 21.32 Mn |
| Sep 30, 2021 | 22.71 Mn |
| Jun 30, 2021 | 23.56 Mn |
| Mar 31, 2021 | 23.82 Mn |
| Dec 31, 2020 | 22.81 Mn |
| Sep 30, 2020 | 23.13 Mn |
| Jun 30, 2020 | 22.53 Mn |
| Mar 31, 2020 | 25.15 Mn |